WSO - April 2023 - 382

382
International Journal of Stroke 18(4)
2.20) compared to antiplatelets or placebo. The authors
conclude that any benefit of OAC for stroke prevention
may be offset by an increased risk of major bleeding
patients and that a well-designed randomized controlled
trial of newer safer OACs is needed in this population.
Finally, I'd like to welcome new members of our editorial
board: Urvashy Gopaul, Andrew Lee, Linxin Li, and
Vasileios-Arsenios Lioutas. Its particularly pleasing to welcome
a number of graduates of the excellent World Stroke
Organization Future leaders program. I'd also like to thank
retiring members: Peter Rothwell, Chris Levi, Natan
Bornstein, who have all been on the board since the journals
inception in 2006!, and Valeria Caso and Gillian Mead.
Thank you all for your enormous contribution.
Hugh S Markus
University of Cambridge, Cambridge, UK
Email: hsm32@medschl.cam.ac.uk
References
1. Mittal P, Quattrocchi G,
Tohidi-Esfahani I, et al.
Antiphospholipid syndrome, antiphospholipid antibodies, and
stroke. Int J Stroke 2023; 18: 383-391.
2. Chen HY, Lee WK, Chang R, et al. Immune thrombocytopenia
and risk of stroke: evidence from a nationwide populationbased
cohort study. Int J Stroke 2022; 18: 408-415.
3. Micieli A, Singh N, Jahn B, et al. Cost-effectiveness of testing
for CYP2C19 loss-of-function carriers following transient
ischemic attack/minor stroke: a Canadian perspective. Int J
Stroke 2022; 18: 416-425.
4. Wang Y, Meng X, Wang A, et al.; CHANCE-2 Investigators.
Ticagrelor versus clopidogrel in CYP2C19 loss-of-function
carriers with stroke or TIA. N Engl J Med 2021; 385: 2520-
2530.
5. Toyoda K, Uchiyama S, Yamaguchi T, et al.; CSPS.com Trial
Investigators. Dual antiplatelet therapy using cilostazol for
secondary prevention in patients with high-risk ischaemic
stroke in Japan: a multicentre, open-label, randomised controlled
trial. Lancet Neurol 2019; 18: 539-548.
6. Uchiyama S, Toyoda K, Omae K, et al. Dual antiplatelet therapy
using cilostazol in patients with stroke and intracranial
arterial stenosis. J Am Heart Assoc 2021; 10: e022575.
7. Uchiyama S, Toyoda K, Okamura S, et al. Dual antiplatelet
therapy with cilostazol in stroke patients with extracranial
arterial stenosis or without arterial stenosis: a subgroup analysis
of the CSPS.com trial. Int J Stroke 2022; 18: 426-432.
8. Nishiyama Y, Kimura K, Otsuka T, et al.; CSPS.com Trial
Investigators. Dual antiplatelet therapy with cilostazol for secondary
prevention in lacunar stroke: subanalysis of the CSPS.
com Trial. Stroke 2023; 54: 697-705.
9. McHutchison C, Blair GW, Appleton JP, et al. Cilostazol for
secondary prevention of stroke and cognitive decline: systematic
review and meta-analysis. Stroke 2020; 51: 2374-2385.
10. Nogueira RG, Abdalkader M, Qureshi MM, et al. Global
impact of COVID-19 on stroke care. Int J Stroke 2021; 16:
573-584.
11. Pandian JD, Panagos PD, Sebastian IA, et al. Maintaining
stroke care during the COVID-19 pandemic in lower- and
middle-income countries: World Stroke Organization Position
Statement endorsed by American Stroke Association and
American Heart Association. Int J Stroke 2022; 17: 9-17.
12. South K, McCulloch L, McColl BW, et al. Preceding infection
and risk of stroke: an old concept revived by the COVID-19
pandemic. Int J Stroke 2020; 15: 722-732.
13. Nannoni S, de Groot R, Bell S, et al. Stroke in COVID-19: a
systematic review and meta-analysis. Int J Stroke 2021; 16:
137-149.
14. Qureshi AI, Baskett WI, Huang W, et al. New cardiovascular
events in the convalescent period among survivors of SARSCoV-2
infection. Int J Stroke 2022; 18: 437-444.
15. Mayer-Suess L, Heidbreder A, Kiechl S, et al. Decline in spontaneous
cervical artery dissection incidence during COVID19
public health measures: evidence for a role of upper
respiratory infections in pathogenesis. Int J Stroke 2023;
18: 433-436.
16. Li W, Seo J, Kokkinidis DG, et al. Efficacy and safety of vitamin-K
antagonists and direct oral anticoagulants for stroke
prevention in patients with heart failure and sinus rhythm: an
updated systematic review and meta-analysis of randomized
clinical trials. Int J Stroke 2022; 18: 392-399.
International Journal of Stroke, 18(4)
http://www.CSPS.com http://www.CSPS.com http://www.CSPS.com
WSO - April 2023

Table of Contents for the Digital Edition of WSO - April 2023
